2 recruiting, 1 completed, 1 not yet recruiting. 2 Phase 2, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Recruiting 1 |
| Phase 3 | 2 | Not yet recruiting 1, Recruiting 1 |
Follow GST-HG141: new trials by email Literature Review of GST-HG141 trials Research Report on GST-HG141
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of GST-HG131&141 Tablets Compared With Placebo in Patients With Chronic Hepatitis B GST-HG141, GST-HG131, GST-HG141 Placebo - Chronic Hepatitis B | Phase 2 | Recruiting | Fujian Akeylink Biotechnology Co., Ltd. | 80 | 2026-07-10 | 2026-07-17 |
| Phase IIIB Extension Clinical Trial of Efficacy and Safety of GST-HG141 (Nairevir) Combined With NAs in Chronic Hepatitis B GST-HG141 - Chronic Hepatitis b | Phase 3 | Not yet recruiting | Fujian Akeylink Biotechnology Co., Ltd. | 576 | 2026-06-26 | 2026-05-14 |
| To Evaluate the Efficacy, Safety and Population Pharmacokinetics of GST-HG141 in Patients With Chronic Hepatitis B (CHB) Who Have an Inadequate Response to Antiviral Drug Treatment GST-HG141, GST-HG141 Placebo - Chronic Hepatitis b | Phase 3 | Recruiting | Fujian Akeylink Biotechnology Co., Ltd. | 526 | 2025-07-24 | 2026-01-23 |
| Evaluation of The Safety, Efficacy and Pharmacokinetic Characteristics of GST-HG141 Tablets GST-HG141 - Chronic Hepatitis b | Phase 2 | Completed | Fujian Akeylink Biotechnology Co., Ltd. | 90 | 2023-01-03 | 2025-03-05 |
Fujian Akeylink Biotechnology Co., Ltd. (4)
China (3)